SCHEMBL1810679

SCHEMBL1810679

Fc1cccc2nc(Br)ncc12

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDGFRB P09619 1/20 0.37
PDGFRA P16234 1/20 0.37
BACE1 P56817 1/20 0.35
ADORA2A P29274 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
PDE10A Q9Y233 1/20 0.34
NPC1 O15118 2/20 0.33
RAB9A P51151 2/20 0.33
C1R P00736 1/20 0.33
PARP1 P09874 2/20 0.33
CCNK O75909 1/20 0.32
CCNA2 P20248 1/20 0.32
CDK2 P24941 1/20 0.32
CDK7 P50613 1/20 0.32
CCNH P51946 1/20 0.32
MNAT1 P51948 1/20 0.32
CDK12 Q9NYV4 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25380543 0.77 IDO1 (0.45) BACE1CYP1A2RAB9AKDM4EMAPT
SCHEMBL26441992 0.77 MAPT (0.43) BACE1CYP1A2NPC1RAB9AC1R
SCHEMBL2882632 0.77 LMNA (0.40) PDGFRBPDGFRAADORA2ACYP1A2PDE10A
SCHEMBL23002965 0.77 MAPT (0.41) PDGFRBPDGFRAADORA2APDE10ANPC1
SCHEMBL558627 0.77 ADORA2A (0.49) PDGFRBPDGFRAADORA2ACYP1A2RAB9A
SCHEMBL31116662 0.74 NPC1 (0.57) PDGFRBPDGFRACYP1A2NPC1RAB9A
SCHEMBL10220808 0.73 CCNE2 (0.36) PDGFRBPDGFRAPDE10ARAB9ACCNA2
SCHEMBL10272460 0.73 PDE10A (0.40) PDGFRBPDGFRAADORA2APDE10APDE7A
SCHEMBL26090878 0.72 BACE1 (0.41) PDGFRBPDGFRABACE1ADORA2ACYP1A2
SCHEMBL15638042 0.69 ALDH1A1 (0.48) CYP1A2CYP3A4CYP2C19NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2321296-A1 SUBSTITUTED 5-AMINOPYRAZOLES AND USE THEREOF Bayer Schering Pharma Aktiengesellschaft (DE) 2011-05-18 EP disclosed
WO-2010020363-A1 SUBSTITUTED 5-AMINOPYRAZOLES AND USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-02-25 WO disclosed